Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges

Page view(s)
18
Checked on Jul 16, 2024
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Title:
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Journal Title:
International Journal of Molecular Sciences
Keywords:
Publication Date:
02 December 2015
Citation:
Seah, Y.F.S.; EL Farran, C.A.; Warrier, T.; Xu, J.; Loh, Y.-H. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges. Int. J. Mol. Sci. 2015, 16, 28614-28634.
Abstract:
Embryonic stem cells (ESCs) are chiefly characterized by their ability to self-renew and to differentiate into any cell type derived from the three main germ layers. It was demonstrated that somatic cells could be reprogrammed to form induced pluripotent stem cells (iPSCs) via various strategies. Gene editing is a technique that can be used to make targeted changes in the genome, and the efficiency of this process has been significantly enhanced by recent advancements. The use of engineered endonucleases, such as homing endonucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and Cas9 of the CRISPR system, has significantly enhanced the efficiency of gene editing. The combination of somatic cell reprogramming with gene editing enables us to model human diseases in vitro, in a manner considered superior to animal disease models. In this review, we discuss the various strategies of reprogramming and gene targeting with an emphasis on the current advancements and challenges of using these techniques to model human diseases.
License type:
http://creativecommons.org/licenses/by-nc-sa/4.0/
Funding Info:
Description:
ISSN:
1661-6596
1422-0067
Files uploaded: